Impact of adjuvant radiotherapy on the survival of women with optimally resected stage III endometrial cancer in the era of modern radiotherapy: a retrospective study

Table 4 Multivariate analysis of potential prognostic factors (n = 154)

	Recurrence-free survival		Overall survival
	HR (95% CI)	p-value^a	HR (95% CI)	p-value^a
Age > 60 years	1.44 (0.75–2.75)	0.277	0.93 (0.34–2.56)	0.884
Non-endometrioid histology	2.95 (1.32–6.61)	0.009	3.27 (0.94–11.34)	0.062
Tumor grade 3	1.90 (0.97–3.75)	0.062	1.38 (0.48–3.98)	0.555
Adjuvant radiotherapy, alone or combined with chemotherapy	0.62 (0.31–0.98)	0.042	0.53 (0.20–1.37)	0.188

HR hazard ratio, CI confidence interval
^aSignificance was tested using multivariate analysis based on the Cox proportional hazards regression model

ISSN: 1748-717X